NFKB1 and neoplasm: The authors found that both JAK/STAT3 and NF-KB signaling pathways regulate the properties of CSCs in ATC cells, and combined treatment with their specific pharmacological inhibitors triggers an additive/synergistic anti-tumor response in ATC sphere formation, speculating the cross-talk between the STAT3 and NF-KB signaling pathways [132].